Similar articles

• Pharmaceuticals and medical devices: FDA oversight.

  Berry MD. Berry MD. Issue Brief Health Policy Track Serv. 2013 Dec 30:1-123. Issue Brief Health Policy Track Serv. 2013. PMID: 24482893 No abstract available.
• Understanding government regulation of the marketing and advertising of medical devices, drugs, and biologics: the challenges of the Internet.

  Reichertz PS. Reichertz PS. Food Drug Law J. 1997;52(3):303-8. Food Drug Law J. 1997. PMID: 10343029 No abstract available.
• The new drug marketing: a consumer protection perspective.

  Woodward D. Woodward D. Food Drug Law J. 1996;51(4):637-50. Food Drug Law J. 1996. PMID: 11797733 No abstract available.
• Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.

  Strawn MN. Strawn MN. J Contemp Health Law Policy. 2003 Spring;19(2):495-520. J Contemp Health Law Policy. 2003. PMID: 14748255 Review. No abstract available.
• Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.

  Kopp SW, Bang HK. Kopp SW, et al. Health Mark Q. 2000;17(3):39-56. doi: 10.1300/J026v17n03_04. Health Mark Q. 2000. PMID: 11010219 Review.